Physician profile
Jaime Nix
NPI 1154098846
$4,265.73
in general payments reported to CMS, 2019-2025
36 companies · $750 in 2025
The $750 reported for 2025 was more than what 80% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $238 · 2022: $1,577 · 2023: $1,064 · 2024: $637 · 2025: $750.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,386 · Education: $64.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,385.50 |
| Education | $64.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $449.51 | 2022-2025 | Ozempic, Rybelsus, Saxenda |
| Amgen INC. | $394.38 | 2021-2025 | Repatha, Otezla, Evenity |
| Abbvie INC. | $375.19 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $349.28 | 2022-2025 | Breztri, Airsupra, Farxiga |
| Lilly USA, LLC | $265.21 | 2022-2025 | Mounjaro, Zepbound |
| Axsome Therapeutics, INC. | $255.79 | 2023-2025 | Auvelity, Symbravo, Sunosi |
| Ardelyx, INC. | $214.81 | 2025 | Ibsrela |
| Pfizer INC. | $191.82 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $159.46 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $157.97 | 2021-2024 | Xifaxan |
| Antares Pharma, INC. | $141.57 | 2022-2024 | Xyosted, Nocdurna, Tlando |
| Harmony Biosciences LLC | $136.78 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $125.59 | 2022 | |
| Glaxosmithkline, LLC. | $111.75 | 2023-2024 | Nucala, Trelegy Ellipta, Arexvy |
| Novartis Pharmaceuticals Corporation | $105.86 | 2022-2025 |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaime Nix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.